177 related articles for article (PubMed ID: 36557034)
1. Kawasaki Disease with Hepatobiliary Manifestations.
Suhaini SA; Azidin AH; Cheah CS; Lee Wei Li W; Khoo MS; Ismail NAS; Ali A
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557034
[No Abstract] [Full Text] [Related]
2. A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns.
Sadeghi P; Izadi A; Mojtahedi SY; Khedmat L; Jafari M; Afshin A; Yarahmadi P; Hosseinali Beigi E
BMC Infect Dis; 2021 Apr; 21(1):368. PubMed ID: 33874899
[TBL] [Abstract][Full Text] [Related]
3. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
[TBL] [Abstract][Full Text] [Related]
4. [Neurological manifestations in atypical Kawasaki disease].
Martínez-Guzmán E; Gámez-González LB; Rivas-Larrauri F; Sorcia-Ramírez G; Yamazaki-Nakashimada M
Rev Alerg Mex; 2017; 64(3):376-380. PubMed ID: 29046034
[TBL] [Abstract][Full Text] [Related]
5. Kawasaki Disease: Beyond IVIG and Aspirin.
Moussa T; Wagner-Weiner L
Pediatr Ann; 2019 Oct; 48(10):e400-e405. PubMed ID: 31609999
[TBL] [Abstract][Full Text] [Related]
6. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
[TBL] [Abstract][Full Text] [Related]
7. Kawasaki disease in Malaysia: Biochemical profile, characterization, diagnosis and treatment.
Cheah CS; Lee WWL; Suhaini SA; Azidin AH; Khoo MS; Ismail NAS; Ali A
Front Pediatr; 2022; 10():1090928. PubMed ID: 36714643
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
Lei WT; Chang LS; Zeng BY; Tu YK; Uehara R; Matsuoka YJ; Su KP; Lee PC; Cavalcante JL; Stubbs B; Lin PY; Wu YC; Hsu CW; Chen TY; Chen YW; Yeh PY; Sun CK; Tseng PT; Kao YH
EBioMedicine; 2022 Apr; 78():103946. PubMed ID: 35306339
[TBL] [Abstract][Full Text] [Related]
9. Painful jaundice revealing Kawasaki disease in a young man.
Granel B; Serratrice J; Ene N; Igual JP; Habib G; Disdier P; Weiller PJ
J Gastroenterol Hepatol; 2004 Jun; 19(6):713-5. PubMed ID: 15151633
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: a population-based study from a tropical country.
Mat Bah MN; Alias EY; Razak H; Sapian MH; Foo FH; Abdullah N
Eur J Pediatr; 2021 Aug; 180(8):2599-2606. PubMed ID: 34086103
[TBL] [Abstract][Full Text] [Related]
11. Kawasaki Disease With Combined Cholestatic Hepatitis and
Huang SW; Lin SC; Chen SY; Hsieh KS
Front Pediatr; 2021; 9():738215. PubMed ID: 35223706
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children.
Yi DY; Kim JY; Choi EY; Choi JY; Yang HR
BMC Pediatr; 2014 Feb; 14():51. PubMed ID: 24548331
[TBL] [Abstract][Full Text] [Related]
13. A Case of Incomplete and Atypical Kawasaki Disease Presenting with Retropharyngeal Involvement.
Isidori C; Sebastiani L; Esposito S
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31491922
[No Abstract] [Full Text] [Related]
14. Low risk of treatment resistance in Down syndrome with Kawasaki disease.
Takatsuki S; Ogata S; Ishii M; Yokozawa M; Ono M; Fujiwara M; Ida H; Motomura H; Moriuchi H; Taketazu M; Kawamura Y; Kawano T; Izumi T; Shiono J; Tsuchiya S; Tsuchiya K; Goushi T; Ichida F; Saji T
Pediatr Int; 2017 Dec; 59(12):1236-1239. PubMed ID: 28960680
[TBL] [Abstract][Full Text] [Related]
15. Kawasaki disease: a comprehensive review of treatment options.
Patel RM; Shulman ST
J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
Durongpisitkul K; Sangtawesin C; Khongphatthanayopthin A; Panamonta M; Sopontammarak S; Sittiwangkul R; Pongpanich B
Asian Pac J Allergy Immunol; 2006 Mar; 24(1):27-32. PubMed ID: 16913186
[TBL] [Abstract][Full Text] [Related]
17. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
18. Kawasaki disease in central area of Northeast Thailand.
Panamonta M; Chaikitpinyo A; Durongpisitkul K; Somchit S; Petcharatana S; Wongswadiwat Y; Kosalaraksa P; Lumbiganon P
J Med Assoc Thai; 2004 Aug; 87(8):887-90. PubMed ID: 15471291
[TBL] [Abstract][Full Text] [Related]
19. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
Wang J; Chen H; Shi H; Zhang X; Shao Y; Hang B; Xu Z; Rong X; Chu M; Qiu H
Pediatr Rheumatol Online J; 2020 Jun; 18(1):48. PubMed ID: 32527316
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of gallbladder enlargement in Kawasaki disease.
Miyazawa A; Matsushima T; Sakakibara H; Akahoshi S; Morikawa Y; Koyama Y; Miyata K; Hataya H; Miura M
Pediatr Int; 2023; 65(1):e15543. PubMed ID: 37493267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
